Buy Micardis through the unique service that maximize your savings

Merck & Co’s angiotensin II receptor antagonist Cozaar (losartan) has become the first and only antihypertensive to be approved in the USA for reducing the risk of stroke in patients with high blood pressure and left ventricular hypertrophy, which can be a precursor to heart failure. However, new labeling for the product indicates that this …

Related Results

…

Interestingly, certain cases of high blood pressure are caused by a kidney problem. The kidneys play a large role in determining what our blood pressure is. The kidneys have a complex system of hormones that affect blood pressure under certain circumstances.

The primary kidney problem that leads to high bl…

DUBLIN, Ireland — Research and Markets (http://www.researchandmarkets.com/research/490602/cardiology_acute) has announced the addition of the “Cardiology - Acute Coronary Syndrome, Anticoagulants” report to their offering.
This repor…

DUBLIN, Ireland — Research and Markets (http://www.researchandmarkets.com/research/ce5f70/thought_leader_ins) has announced the addition of the “Thought Leader Insight & Analysis: Non-Interventional Cardiology” report to their offering.
This report provides in-depth analysis of the market and pipeline from the perspective of global thought…

Clinical Question: Are angiotensin receptor blockers (ARBs) as good as angiotensin-converting enzyme (ACE) inhibitors at preventing the progression of nephropathy?
Setting: Outpatient (any)
Study Design: Randomized controlled trial (double-blinded)
Allocation: Uncertain
Synopsis: In this study, 250 participants with diabetes who had mild to moderate hypertension and evidence of early nephropathy (i.e., urinary albumin excretion rate between 11 and 999 mcg…

Drug-induced pancreatitis is estimated to be responsible for nearly 2% of cases of acute pancreatitis. (1) Angiotensin-converting enzyme (ACE) inhibitors are some of the most widely prescribed medications. The occurrence of acute pancreatitis with several differen…

Treatment with an ACE inhibitor drug was as effective in reducing deaths, heart attacks and stroke in a high-risk group of patients as a newer and more expensive angiotensin-receptor blocker (ARB) drug, a large international study has found.
The study of more than 17,000 people with coronary artery disease or diabetes found no …

New scientific approaches for the prevention and acute treatment of stroke were the focus at the 12th European Stroke Conference in Valencia, Spain, last week. During the symposium and subsequent press conference, Germany’s Boehringer Ingelheim presented its comprehensive cerebrovascular protection program for acute and secondary stroke.

Most Popular
10 Jobs That Pay $30 An Hour
Public Speaking: 7 Secrets Of Great Public Speakers
…

CHICAGO (AFP) — A new drug for treating high blood pressure, telmisartan, is as effective as the popular drug ramipril but with fewer side effects, according to a study published Monday.
After four and a half years of study, researchers found that temisartan (marketed as Micardis, Pritor or Kinzal) and ramipril (Trita…

Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, April 16 (DDMAC). A journal ad and a sales aid for Micardis (telmisartan) tablets, submitted via Form 2253, were deemed misleading for implying superiority over other angiotensin II receptor blockers, insufficient contextual information for a pie chart and a graph that presented clinical data inaccurately.

Most Popular
Public Speaking: 7 Secrets Of Great Public Speakers
10 Jobs That Pay $30 A…